Netherlands Diagnostic Imaging Equipment Market Size
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 597.10 Million |
| Market Size (2029) | USD 733.97 Million |
| CAGR (2024 - 2029) | 4.21 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Netherlands Diagnostic Imaging Equipment Market Analysis
The Netherlands Diagnostic Imaging Equipment Market size is estimated at USD 597.10 million in 2024, and is expected to reach USD 733.97 million by 2029, growing at a CAGR of 4.21% during the forecast period (2024-2029).
Factors such as the rise in the prevalence of chronic diseases, technological advancement in imaging modalities, and the increasing geriatric population are actively affecting the growth of the market studied.
The increasing prevalence of cancer in the Netherlands is a significant driving factor in the growth of the diagnostic imaging equipment market. As new cancer cases continue to rise, there is a growing demand for advanced diagnostic tools to support early detection and effective treatment planning. For instance, according to Globocan 2022, the estimated number of new cancer cases among males is projected to increase by 31.9%, from 69.6 thousand in 2022 to 91.7 thousand in 2045. Similarly, the number of new cases among females is expected to rise by 21.7%, from 62.7 thousand in 2022 to 76.3 thousand in 2045.
This substantial increase in cancer incidence highlights the need for cutting-edge diagnostic imaging technologies, such as CT scanners, MRI machines, and ultrasound devices, to meet the growing demands of healthcare providers in the country. Therefore, the rising prevalence of cancer cases in the Netherlands is fueling the expansion of the diagnostic imaging equipment market.
Moreover, the geriatric population is more prone to chronic diseases and other age-related diseases. The prevalence of the target population in the Netherlands is high, and it is expected to rise in the future. According to the 2024 update by the Statistics Netherlands (CBS), the population aged 65 years and above was 3.6 million in 2024, which accounted for 20.5% of the total population in the Netherlands. The geriatric population in the country is expected to grow by 50% over the coming years. This increase in the elderly population is expected to create demand for diagnostic procedures, ultimately garnering the demand for diagnostic imaging equipment in the country.
Additionally, advancements in technology for more accurate methods for diagnosing bladder cancer, along with partnerships and funding from key players, are boosting the market growth. For instance, in February 2024, Scinvivo, a medtech startup based in Eindhoven, the Netherlands, secured EUR 4.7 million (USD 5.03 million) in funding to revolutionize bladder cancer diagnostics. Scinvivo's technology utilizes optical coherence tomography (OCT) to provide high-resolution images of bladder tissue, potentially enabling precise minimally invasive surgeries. This investment signifies a major step for Scinvivo and its innovative approach to bladder cancer diagnostics.
Such investments between healthcare institutions and key market players are expected to bolster the use of diagnostic imaging equipment for the management of various chronic diseases, thereby boosting market growth.
However, expensive procedures and equipment and side effects of diagnostic imaging are likely to impede market growth.
Netherlands Diagnostic Imaging Equipment Market Trends
The Oncology Segment is Expected to Witness Growth During the Forecast Period
Diagnostic imaging is vital in interventional oncology, chemotherapy, and radiation therapy. Computed tomography is a highly beneficial and preferred imaging method for many conditions, including trauma patients. Positron emission tomography (PET) and single photon emission computed tomography (SPECT) are also used in cancer diagnostic imaging. Hybrid medical devices such as PET/CT or PET/MRI can further contribute to the segment's growth.
According to the Netherlands Comprehensive Cancer Organisation (IKNL), in October 2022, 1 in 13 people in the Netherlands are estimated to be diagnosed with cancer by 2032, and the number of cancer cases is expected to rise from 800.000 in 2022 to nearly 1.4 million by 2032. Hence, the country's high burden of cancer cases is projected to increase the demand for diagnostic imaging and is expected to augment the segment growth in the coming years.
Furthermore, the government's funding to expedite research and development in the oncology segment is projected to boost the demand in the market segment. For instance, in February 2023, the Netherlands Cancer Institute (NKI) secured EUR 15 million (USD 16.0 million) in funding for the NL-BioImaging consortium. Research using high-powered microscopy can lead to breakthroughs in understanding diseases and developing new diagnostic tools. The NL-BioImaging consortium's focus on making these techniques accessible could accelerate innovation in imaging diagnostics. These government initiatives are expected to bolster the demand for oncology diagnostic imaging equipment, which is projected to augment the segment's growth during the forecast period.
The Mammography Segment is Expected to Hold a Significant Share of the Market
Mammography is an X-ray imaging technique used to examine the breast for the early detection of cancer and other breast diseases. There are two types of mammograms, namely screening and diagnostic. A diagnostic mammogram is done for people who have a lump or other signs and symptoms of breast cancer, and along with other tests, it helps confirm whether the patient has cancer or not.
Factors such as increasing breast cancer screening and the Dutch government's breast cancer screening programs are expected to create demand for these mammography devices and garner the segment's growth.
The Government of the Netherlands designed a National Breast Cancer Screening Programme for women between 50 and 75 years of age, and the women of the age group are invited for a mammogram once every 2 years. This is increasing awareness regarding breast cancer and the benefits of mammogram screening.
As per a report published by the Netherlands Comprehensive Cancer Organisation (IKNL) in October 2023, in 2022, nearly 88.6% of the total women population in the country was invited to the national breast cancer screening program, out of which 70.7% of the invited women participated. This focus on quality can lead to increased investment in advanced mammography technology. Therefore, increasing awareness regarding breast cancer screening is expected to propel the demand for diagnostic imaging equipment in the country.
In addition, in March 2024, the Dutch National Breast Cancer Screening Programme stated that the high prevalence of breast cancer in the Netherlands, with an estimated 1 in 8 women developing the disease and nearly 14,000 diagnosed annually, necessitates a robust mammography screening program. This translates to a significant and constant demand for mammography services to ensure early detection and improve patient outcomes. Thus, the increased adoption of advanced mammography technologies is further strengthening the market.
Thus, the country's commitment to a successful national screening program, coupled with the high prevalence of breast cancer, positions mammography as a vital diagnostic tool. Also, the active involvement of the government is expected to create demand for the availability of technologically advanced mammography equipment, further fueling the segment's growth.
Netherlands Diagnostic Imaging Equipment Industry Overview
The Dutch diagnostic imaging equipment market is semi-consolidated due to the presence of many companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known. Some of the key market players are Canon Medical Systems Corporation, Carestream Health Inc., Esaote SpA, FUJIFILM Holdings Corporation, GE Healthcare, Mindray Medical International Limited, Hologic Corporation, Koninklijke Philips NV, Shimadzu Medical, and Siemens Healthineers.
Netherlands Diagnostic Imaging Equipment Market Leaders
-
GE Healthcare
-
FUJIFILM Holdings Corporation
-
Siemens Healthineers
-
Koninklijke Philips N.V.
-
Carestream Health Inc.
*Disclaimer: Major Players sorted in no particular order
Netherlands Diagnostic Imaging Equipment Market News
- October 2023: Royal Philips, a health technology company based in the Netherlands, introduced its Philips CT 3500. This state-of-the-art CT system is designed to address the demands of routine radiology and high-volume screening programs. By leveraging AI-powered workflow enhancements and advanced image reconstruction capabilities, the Philips CT 3500 ensures increased productivity and first-time-right imaging, thereby improving the speed and accuracy of diagnoses.
- August 2023: GE HealthCare launched the Vscan Air SL handheld ultrasound device at the European Society of Cardiology (ESC) Congress in Amsterdam, Netherlands. This FDA-cleared device features sector and linear arrays, allowing for seamless cardiac and vascular assessments at the point of care.
Netherlands Diagnostic Imaging Equipment Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Technological Advancement in Imaging Modalities
4.2.3 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 Expensive Procedures and Equipment
4.3.2 Side Effects of Diagnostic Imaging
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Modality
5.1.1 Magnetic Resonance Imaging
5.1.1.1 Low and Mid-field MRI Systems (Less Than 1.5 T)
5.1.1.2 High-field MRI Systems (1.5-3 T)
5.1.1.3 Very High and Ultra High-field MRI Systems (3T and More)
5.1.2 Computed Tomography
5.1.2.1 Low-end Scanners (~16-Slice)
5.1.2.2 Mid-range Scanners (~64-Slice)
5.1.2.3 High-end Scanners (128-Slice and More)
5.1.3 Ultrasound
5.1.3.1 2D Ultrasound
5.1.3.2 3D Ultrasound
5.1.3.3 Other Ultrasound
5.1.4 X-Ray
5.1.4.1 Analog Systems
5.1.4.2 Digital Systems
5.1.5 Nuclear Imaging
5.1.5.1 Positron Emission Tomography (PET)
5.1.5.2 Single Photon Emission Computed Tomography (SPECT)
5.1.6 Fluoroscopy
5.1.7 Mammography
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Gastroenterology
5.2.6 Gynecology
5.2.7 Other Applications
5.3 By End User
5.3.1 Hospital
5.3.2 Diagnostic Centers
5.3.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health Inc.
6.1.3 Esaote SpA
6.1.4 FUJIFILM Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Mindray Medical International Limited
6.1.7 Hologic Corporation
6.1.8 Koninklijke Philips NV
6.1.9 Shimadzu Medical
6.1.10 Siemens Healthineers
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Netherlands Diagnostic Imaging Equipment Industry Segmentation
As per the scope of the report, the diagnostic imaging equipment market covers a wide array of medical devices used for diagnostic purposes. It has many oncological, orthopedic, gastroenterology, and gynecological applications.
The Dutch diagnostic imaging equipment market is segmented by modality (magnetic resonating imaging, computed tomography, ultrasound, X-ray, nuclear imaging, fluoroscopy, and mammography), application (cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and other applications), and end user (hospital, diagnostic centers, and other end users). The report offers market sizes and forecasts in terms of value (USD) for all the above segments.
| By Modality | |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| Fluoroscopy | |||||
| Mammography |
| By Application | |
| Cardiology | |
| Oncology | |
| Neurology | |
| Orthopedics | |
| Gastroenterology | |
| Gynecology | |
| Other Applications |
| By End User | |
| Hospital | |
| Diagnostic Centers | |
| Other End Users |
Netherlands Diagnostic Imaging Equipment Market Research FAQs
How big is the Netherlands Diagnostic Imaging Equipment Market?
The Netherlands Diagnostic Imaging Equipment Market size is expected to reach USD 597.10 million in 2024 and grow at a CAGR of 4.21% to reach USD 733.97 million by 2029.
What is the current Netherlands Diagnostic Imaging Equipment Market size?
In 2024, the Netherlands Diagnostic Imaging Equipment Market size is expected to reach USD 597.10 million.
Who are the key players in Netherlands Diagnostic Imaging Equipment Market?
GE Healthcare, FUJIFILM Holdings Corporation, Siemens Healthineers, Koninklijke Philips N.V. and Carestream Health Inc. are the major companies operating in the Netherlands Diagnostic Imaging Equipment Market.
What years does this Netherlands Diagnostic Imaging Equipment Market cover, and what was the market size in 2023?
In 2023, the Netherlands Diagnostic Imaging Equipment Market size was estimated at USD 571.96 million. The report covers the Netherlands Diagnostic Imaging Equipment Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Netherlands Diagnostic Imaging Equipment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Netherlands Diagnostic Imaging Equipment Industry Report
Statistics for the 2024 Netherlands Diagnostic Imaging Equipment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Netherlands Diagnostic Imaging Equipment analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
